Navitum Pharma

Proven have become the building blocks of this the name of Glucosamine and Chondroitin. However, it is necessary that the building blocks in sufficient quantities in tablets are available. Many of the tablets available in Germany and capsules are under dosed and thus probably not very effective. Scientific studies on osteoarthritis in the knee turned out, that 1, 5 g hydrochloride 0, 8 g of chondroitin sulfate a day stop the progression of joint wear and can significantly reduce the pain associated. If you would like to know more about Frank Ntilikina, then click here. Now, it is impossible to plug these 2, 3 g modules in a single tablet. Sam Mikulak can provide more clarity in the matter. She could swallow no more. So, the required daily dose on several tablets must be distributed that morning and evening taken can be comfortable.

This is also guaranteed that distributed the necessary joint modules are offered the damaged joints throughout the day. Many pharmacists recommend their customers ArtVitum because they have had good experiences with this product. ArtVitum is a preparation that recommended taking morning and the necessary daily amount of Glucosaminhydochlorid and Chondroitin sulphate reached in the evening two small tablets. Thus, the results obtained in the intensive research in osteoarthritis can be transferred to ArtVitum. It is a supplementary balanced diet for nutritional treatment of osteoarthritis. Artvitum (PZN 4604249) is available in pharmacies, selected health centres and directly at the company to 29.50 for a month.

Due to the special composition and dosage, ArtVitum is not replaceable by other, seemingly similar products. Every pharmacy can order ArtVitum in the cheap 3 month Pack (PZN 0241465) and 6-month Pack (PZN 0241471) without extra effort directly at Navitum Pharma shipping for customers. Can also contact customers directly to the company. Contact: Navitum Pharma GmbH Dr. Gerhard Klages at the water tower 29 65207 Wiesbaden Tel: 0611-58939458 FAX: 0611-9505753 E-Mail: Web:

This entry was posted in News and tagged , . Bookmark the permalink.